Merkle GmbH (quality control, primary and secondary packaging, batch release; manufacturing of unpackaged product)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of schizophrenia, bipolar disorder (including manic and depressive episodes, as well as for the prevention of relapses), and as adjunctive therapy for major depressive episodes.
Dosage form: tablets, film-coated, prolonged release
Active substance Dosage quetiapine 50 mg ATC: N05AH04
-
The drug is used for the treatment of schizophrenia, bipolar disorder (including manic and depressive episodes, as well as for the prevention of their recurrence), and as adjunctive therapy for major depressive episodes.
Dosage form: tablets, film-coated, prolonged release
Active substance Dosage quetiapine 150 mg ATC: N05AH04
-
The drug is used for the treatment of schizophrenia, bipolar disorder (including manic and depressive episodes, as well as for the prevention of their recurrence), and as adjunctive therapy for major depressive episodes.
Dosage form: tablets, film-coated, prolonged release
Active substance Dosage quetiapine 200 mg ATC: N05AH04
-
The drug is used for the treatment of schizophrenia, bipolar disorder (including manic and depressive episodes, as well as for the prevention of relapses), and as adjunctive therapy in major depressive disorders.
Dosage form: tablets, film-coated, prolonged release
Active substance Dosage quetiapine 300 mg ATC: N05AH04
-
The drug is used for the treatment of schizophrenia, bipolar disorder (manic and depressive episodes, as well as for the prevention of relapses), and as adjunctive therapy for major depressive episodes.
Dosage form: tablets, film-coated, prolonged release
Active substance Dosage quetiapine 400 mg ATC: N05AH04